A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: paclitaxel|DRUG: pertuzumab [Perjeta]|DRUG: trastuzumab emtansine [Kadcyla]|DRUG: paclitaxel|DRUG: trastuzumab emtansine [Kadcyla]
Sponsor: Genentech, Inc.